Intramuscular injections of virus-like particles studded with full-length HER2 or oncogenic variant Delta16HER2 extracellular domains in GEMMs significantly delayed or prevented tumor formation along with eliciting a robust anti-HER-2 production immune response [76]. This evidence concerns the gene ERBB2 and neoplasm.